Physician profile
Debra Lin
NPI 1326458001
$2,497.05
in general payments reported to CMS, 2019-2025
23 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $247 · 2021: $306 · 2022: $906 · 2023: $156 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $469.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $630.27 | 2019-2022 | |
| Applied Medical Resources Corporation | $556.87 | 2022 | |
| Abbott Laboratories | $313.64 | 2025 | Eterna |
| Boston Scientific Corporation | $155.76 | 2023 | |
| Exeltis, USA INC. | $149.80 | 2019-2022 | |
| Myovant Sciences INC. | $109.95 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $89.04 | 2021-2022 | |
| Evofem Biosciences, INC. | $78.92 | 2021-2022 | |
| Avion Pharmaceuticals | $40.61 | 2020-2022 | |
| Mylan Pharmaceuticals INC. | $40.42 | 2019-2022 | |
| Organon LLC | $38.80 | 2021-2022 | |
| Hologic Sales and Service, LLC | $36.74 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $36.02 | 2019 | |
| Pfizer INC. | $34.69 | 2022 | |
| Merck Sharp & Dohme LLC | $34.09 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $28.61 | 2022 | |
| Agile Therapeutics, INC. | $23.71 | 2022 | |
| Novum Pharma, LLC | $21.27 | 2019 | |
| Roche Diagnostics Corporation | $18.71 | 2019 | |
| Astellas Pharma US INC | $15.31 | 2022 | |
| Duchesnay USA Incorporated | $14.93 | 2019 | |
| Therapeuticsmd, INC. | $14.73 | 2020 | |
| Acessa Health INC. | $14.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.